XTalks
AUGUST 3, 2022
Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Opzelura Vitiligo Med Wins FDA Approval as First Treatment for Repigmentation. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.
pharmaphorum
DECEMBER 1, 2022
To ease this burden, the life sciences industry has been searching for ways to make clinical trials more accessible for patients and to drive participation numbers, increase participant diversity, and improve overall patient experience. Build a base in the community. Keep it simple. In fact, the opposite is true.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Velocity Clinical Research
OCTOBER 21, 2024
This is vital if we’re to ensure that drug trials are inclusive and deliver results that are representative of the entire population. Historically, clinical trial sites have been concentrated in urban centers or tied to academic institutions. For independent clinical trial sites, this is currently unattainable.
XTalks
SEPTEMBER 11, 2020
Clinical trials, however, don’t reflect that diversity. A study published in JAMA Oncology found that in cancer drug trials conducted between 2008 and 2018, nearly two-thirds of participants were non-Hispanic whites. When trial populations don’t match the broader patient base, the treatments they produce aren’t as effective.
XTalks
APRIL 26, 2021
Given the success of Oxford’s Phase II trial, the study investigators are now gearing up for a Phase III licensure trial to assess large-scale safety and efficacy in 4,800 children aged 5 to 36 months across four countries in Africa. Developing an efficacious vaccine against malaria has been a huge challenge.
XTalks
MAY 16, 2023
RELATED: New Report Highlights Major Barriers to IPF Disease Management Clinical trials for pulmonary fibrosis play a crucial role in advancing our understanding of the disease and developing new treatment options. They aim to improve patient outcomes, slow disease progression and enhance quality of life.
Advarra
AUGUST 16, 2022
That is part of the responsibility of the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER). Department for Health and Human Services (DHHS), prepared guidance on expedited programs for sponsors of orphan drug trials. These centers, in conjunction with the FDA and U.S.
Expert insights. Personalized for you.
52 
Let's personalize your content